LYTIR

Company · CYTK

Cytokinetics, Incorporated

Name as listed on its exchange; filed with the SEC as CYTOKINETICS INC.

Nasdaq's symbol directory lists CYTK on Nasdaq as “Cytokinetics, Incorporated - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 32 occasions ($23.1M); 5 planned-sale notices; 2 filings by holders of 5% or more; 2 congressional trade disclosures; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $23.1M in total.Jun: Insider sales $4.3MJul: Insider sales $4.9MAug: Insider sales $2.1MSep: Insider sales $8.6MOct: Insider sales $910KNov: Insider sales $2.3MDecJanFebMarAprMayJunJulAugSepOctNov$8.6M
Insider purchases above the line: $0Insider sales below: $23.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Blum Robert I, President & CEO sold on 12 days all under a 10b5-1 plan latest Nov 16, 2026 sold $12.7M
  2. Lee Sung, EVP, Chief Financial Officer sold on 3 days all under a 10b5-1 plan latest Jul 1, 2026 sold $3.6M
  3. Callos Andrew, EVP, Chief Commercial Officer sold on 3 days all under a 10b5-1 plan latest Aug 31, 2026 sold $3.1M
  4. Malik Fady Ibraham, EVP Research & Development sold on 9 days all under a 10b5-1 plan latest Nov 17, 2026 sold $2.2M
  5. Hessekiel Jeffrey, Chief Legal & Admin Officer sold on 1 day latest Nov 17, 2026 sold $795K
  6. PARSHALL B LYNNE sold on 2 days all under a 10b5-1 plan latest Nov 9, 2026 sold $631K
  7. Landry Robert E sold on 2 days all under a 10b5-1 plan latest Sep 15, 2026 sold $147K
Every trade (32)
  1. SELLHessekiel Jeffrey, Chief Legal & Admin Officer sold Nov 17, 2026 15,106 shares filing $795K
  2. SELLMalik Fady Ibraham, EVP Research & Development sold Nov 17, 2026 3,500 shares 2 legs combined 10b5-1 plan (scheduled) filing $181K
  3. SELLBlum Robert I, President & CEO sold Nov 16, 2026 7,500 shares 3 legs combined 10b5-1 plan (scheduled) filing $401K
  4. SELLPARSHALL B LYNNE sold Nov 9, 2026 5,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $274K
  5. SELLMalik Fady Ibraham, EVP Research & Development sold Nov 3, 2026 3,500 shares 10b5-1 plan (scheduled) filing $220K
  6. SELLBlum Robert I, President & CEO sold Nov 2, 2026 7,500 shares 10b5-1 plan (scheduled) filing $471K
  7. SELLMalik Fady Ibraham, EVP Research & Development sold Oct 20, 2026 3,500 shares 10b5-1 plan (scheduled) filing $224K
  8. SELLBlum Robert I, President & CEO sold Oct 12, 2026 7,500 shares 10b5-1 plan (scheduled) filing $472K
  9. SELLMalik Fady Ibraham, EVP Research & Development sold Oct 6, 2026 3,500 shares 10b5-1 plan (scheduled) filing $215K
  10. SELLBlum Robert I, President & CEO sold Sep 28, 2026 7,500 shares 10b5-1 plan (scheduled) filing $491K
  11. SELLMalik Fady Ibraham, EVP Research & Development sold Sep 22, 2026 3,500 shares 10b5-1 plan (scheduled) filing $239K
  12. SELLBlum Robert I, President & CEO sold Sep 15, 2026 97,926 shares 10b5-1 plan (scheduled) filing $6.8M
  13. SELLLandry Robert E sold Sep 15, 2026 1,000 shares 10b5-1 plan (scheduled) filing $72K
  14. SELLBlum Robert I, President & CEO sold Sep 14, 2026 7,500 shares 10b5-1 plan (scheduled) filing $551K
  15. SELLLandry Robert E sold Sep 11, 2026 1,000 shares 10b5-1 plan (scheduled) filing $75K
  16. SELLPARSHALL B LYNNE sold Sep 1, 2026 5,000 shares 10b5-1 plan (scheduled) filing $357K
  17. SELLCallos Andrew, EVP, Chief Commercial Officer sold Aug 31, 2026 10,000 shares 10b5-1 plan (scheduled) filing $702K
  18. SELLBlum Robert I, President & CEO sold Aug 31, 2026 7,500 shares 10b5-1 plan (scheduled) filing $527K
  19. SELLMalik Fady Ibraham, EVP Research & Development sold Aug 18, 2026 3,500 shares 10b5-1 plan (scheduled) filing $265K
  20. SELLBlum Robert I, President & CEO sold Aug 10, 2026 7,500 shares 10b5-1 plan (scheduled) filing $576K
  21. SELLCallos Andrew, EVP, Chief Commercial Officer sold Jul 30, 2026 14,000 shares 10b5-1 plan (scheduled) filing $1.1M
  22. SELLBlum Robert I, President & CEO sold Jul 27, 2026 7,500 shares 10b5-1 plan (scheduled) filing $607K
  23. SELLMalik Fady Ibraham, EVP Research & Development sold Jul 21, 2026 3,500 shares 10b5-1 plan (scheduled) filing $282K
  24. SELLBlum Robert I, President & CEO sold Jul 13, 2026 7,500 shares 2 legs combined 10b5-1 plan (scheduled) filing $615K
  25. SELLMalik Fady Ibraham, EVP Research & Development sold Jul 7, 2026 3,500 shares 10b5-1 plan (scheduled) filing $303K
  26. SELLCallos Andrew, EVP, Chief Commercial Officer sold Jul 1, 2026 15,000 shares 10b5-1 plan (scheduled) filing $1.3M
  27. SELLBlum Robert I, President & CEO sold Jul 1, 2026 7,500 shares 10b5-1 plan (scheduled) filing $637K
  28. SELLLee Sung, EVP, Chief Financial Officer sold Jul 1, 2026 1,112 shares 10b5-1 plan (scheduled) filing $98K
  29. SELLLee Sung, EVP, Chief Financial Officer sold Jun 29, 2026 3,134 shares 10b5-1 plan (scheduled) filing $266K
  30. SELLLee Sung, EVP, Chief Financial Officer sold Jun 24, 2026 38,730 shares 10b5-1 plan (scheduled) filing $3.2M
  31. SELLMalik Fady Ibraham, EVP Research & Development sold Jun 23, 2026 3,500 shares 10b5-1 plan (scheduled) filing $278K
  32. SELLBlum Robert I, President & CEO sold Jun 15, 2026 7,500 shares 10b5-1 plan (scheduled) filing $528K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. B LYNNE PARSHALL filed Nov 9, 2026 Director 5,000 shares planned sale date 11/09/2026 filing $268K
  2. FADY MALIK filed Oct 20, 2026 Officer 16,386 shares planned sale date 10/20/2026 filing $1.0M
  3. ROBERT BLUM filed Oct 13, 2026 Director 22,500 shares planned sale date 10/12/2026 filing $1.4M
  4. Robert I. Blum filed Sep 15, 2026 President, CEO, Director 97,926 shares planned sale date 09/15/2026 filing $7.1M
  5. ROBERT LANDRY filed Sep 11, 2026 Director 2,000 shares planned sale date 09/11/2026 filing $147K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 7,143,229 shares filing 5.1%
  2. Wellington Management Group LLP filed Aug 13, 2026 Schedule 13G/A passive filing 5.12%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase Sep 29, 2026 reported Oct 12, 2026 one of 57 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Jun 30, 2026 reported Jul 2, 2026 one of 66 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 4, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.